» Articles » PMID: 22253012

JC Virus Load in Cerebrospinal Fluid and Transcriptional Control Region Rearrangements May Predict the Clinical Course of Progressive Multifocal Leukoencephalopathy

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2012 Jan 19
PMID 22253012
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Progressive multifocal leukoencephalopathy (PML) is a severe disease of the central nervous system (CNS), caused by infection with the Polyomavirus JC virus (JCV). Because there are no known treatments or prognostic factors, we performed a long-term study focusing mainly on cerebrospinal fluid (CSF) samples from PML patients to describe the virological features akin to the different forms of the disease. Twenty-eight PML patients were enrolled: 10 HIV-1+ patients with classical PML (CPML), 9 HIV-1+ patients with slowly progressing or stable neurological symptoms (benign PML), 3 HIV-1+ asymptomatic patients, and 6 HIV-1-negative patients. CSF, urine, and blood samples were collected at the enrollment (baseline) and every 6 months afterwards when possible. The JCV DNA and HIV-1 RNA loads were determined, and the JCV strains were characterized. At baseline, the mean CSF JCV load was log 6.0 ± 1.2 copies/ml for CPML patients, log 4.0 ± 1.0 copies/ml for benign PML patients, log 4.2 ± 0.5 copies/ml for asymptomatic PML patients, and log 5.8 ± 1.3 copies/ml for HIV-1-negative PML patients (CPML vs. benign: P < 0.01; CPML vs. asymptomatic: P < 0.05; HIV-1 negative vs. benign: P < 0.01). Organization of the JCV transcriptional control region (TCR) showed unusual archetype structures in two long-term survival patients; the NF1 sequence was found most commonly, whereas the Sp1 binding site was the most common for both CPML patients and HIV-1 negative patients. Our results suggest that the JCV load in the CSF and the organization of the TCR should be considered as indicators of PML clinical outcome.

Citing Articles

Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital.

Ligero-Lopez J, Sanchez-Castellano M, Falces-Romero I, Montero-Vega M, Garcia-Rodriguez J J Neurovirol. 2023; 29(5):598-604.

PMID: 37470903 DOI: 10.1007/s13365-023-01158-8.


Rapid-progressing progressive multifocal leukoencephalopathy in two patients newly diagnosed with HIV: case series and review of literature.

Badura B, Barczak S, Mikula T, Wiercinska-Drapalo A J Neurovirol. 2023; 29(1):8-14.

PMID: 36774452 PMC: 10089993. DOI: 10.1007/s13365-023-01115-5.


Database and Statistical Analyses of Transcription Factor Binding Sites in the Non-Coding Control Region of JC Virus.

Nakamichi K, Shimokawa T Viruses. 2021; 13(11).

PMID: 34835120 PMC: 8620444. DOI: 10.3390/v13112314.


Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.

Cortese I, Reich D, Nath A Nat Rev Neurol. 2020; 17(1):37-51.

PMID: 33219338 PMC: 7678594. DOI: 10.1038/s41582-020-00427-y.


Structural Analysis of Merkel Cell Polyomavirus (MCPyV) Viral Capsid Protein 1 (VP1) in HIV-1 Infected Individuals.

Prezioso C, Bianchi M, Obregon F, Ciotti M, Sarmati L, Andreoni M Int J Mol Sci. 2020; 21(21).

PMID: 33121182 PMC: 7663277. DOI: 10.3390/ijms21217998.


References
1.
Vaz B, Cinque P, Pickhardt M, Weber T . Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. J Neurovirol. 2000; 6(5):398-409. DOI: 10.3109/13550280009018304. View

2.
Martin J, King D, Slauch J, Frisque R . Differences in regulatory sequences of naturally occurring JC virus variants. J Virol. 1985; 53(1):306-11. PMC: 255040. DOI: 10.1128/JVI.53.1.306-311.1985. View

3.
Berger J, Levy R, Flomenhoft D, Dobbs M . Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol. 1998; 44(3):341-9. DOI: 10.1002/ana.410440309. View

4.
Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M . Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis. 2005; 40(5):738-44. DOI: 10.1086/427698. View

5.
Pagani E, Delbue S, Mancuso R, Borghi E, Tarantini L, Ferrante P . Molecular analysis of JC virus genotypes circulating among the Italian healthy population. J Neurovirol. 2003; 9(5):559-66. DOI: 10.1080/13550280390241269. View